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ABSTRACT:  
 
PURPOSE: Intra-tumour uptake heterogeneity in PET quantified through textural features for 
response to therapy has been investigated in several studies, including assessment of their 
robustness with respect to reconstruction and physiological reproducibility. However, there 
has been no thorough assessment of the potential impact of pre-processing steps on the 
resulting quantification and its predictive value. The goal of this work was to assess the 
robustness of PET heterogeneity textural features with respect to the delineation of functional 
volumes and partial volume effects (PVE) correction (PVC). 
 
METHODS: Fifty patients with oesophageal cancer were retrospectively analyzed. PVC of 
each PET image was performed. Tumour volumes were determined using fixed (FT) and 
adaptive thresholding (AT), and the fuzzy locally adaptive Bayesian (FLAB) algorithm and 
heterogeneity was quantified using local and regional textural features. Differences in the 
absolute quantification values of the image derived parameters considered were assessed 
using Bland-Altman analysis. The impact on their predictive value for the identification of 
patient non-responders was assessed by comparing areas under the receiver operating 
characteristic curves. 
RESULTS: Heterogeneity parameters were more dependent on delineation than on PVC. The 
parameters most sensitive to delineation and PVC were among the regional ones (intensity 
variability and size zone variability), whereas local parameters such as entropy and 
homogeneity were the most robust. Despite the large differences in absolute values obtained 
from different delineation methods or after PVC, these differences did not necessarily 
translate into a significant impact on their predictive value. 
CONCLUSIONS: Parameters such as entropy, homogeneity, dissimilarity (for local 
heterogeneity characterization) or zone percentage (for regional characterization) should be 
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privileged. This selection is based on a demonstrated high differentiation power in terms of 
predicting response, as well as a significant robustness with respect to the delineation method 
used and PVE. 
 
Keywords: 18FDG-PET/CT, heterogeneity, textural features, tumour delineation, partial 
volume effects correction, response to therapy prediction. 
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18F-FDG Positron Emission Tomography/Computed Tomography (PET/CT) has been 
established as a powerful imaging technique mainly for diagnostic oncology applications [1]. 
It has been also increasingly considered for therapy applications, delineating gross tumour 
volumes in external beam radiotherapy treatment planning [2] and/or in monitoring response 
to therapy [3]. Within the specific context of response to therapy prediction or assessment, 
PET image derived indices such as metabolically active tumour volumes (MATV), mean 
standardized uptake values (SUVmean) and derived total lesion glycolysis (TLG, equal to 
MATV×SUVmean) have been shown to provide a more accurate assessment of tumour burden 
with potentially higher predictive and prognostic value compared to standard maximum or 
peak SUV measurements (SUVmax, SUVpeak) for  a variety of cancer models including lung 
[4], esophagus [5], head&neck [6], rectum [7], breast [8], pleural mesothelioma [9] and non-
Hodgkin lymphomas [10]. 
More recently, intra-tumour uptake heterogeneity has been identified as a potential source of 
treatment failure [11] and its characterization through 18F-FDG PET imaging is currently 
generating a substantial amount of interest [12-15]. Such characterization provides additional 
and complementary PET image derived quantitative indices with potential value as already 
demonstrated in predicting therapy response or as prognostic factors in several cancers 
including lung [16], sarcoma [17], oesophageal [18, 19] and rectal cancer [20]. A variety of 
methodologies has been proposed in order to assess intra-tumour uptake heterogeneity, 
including visual assessment [21], SUV coefficient of variation (SUVcov) [20], area under the 
curve of the cumulative histogram (CHAUC) [22] and textural features (TF) analysis [18]. 
TF analysis can potentially provide the most versatile range of indices that may be used to 
characterize uptake heterogeneity within the delineated tumour volume. However, recent 
studies have shown that only a limited number of these TF derived indices are robust with 
respect to the clinical range of image reconstruction algorithms and acquisitions protocols 
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[23], and reproducible with respect to physiological variability assessed on double baseline 
FDG PET scans [24]. Within the same context it has also been hypothesized that 
heterogeneity quantification could be dependent on the necessary functional tumour volume 
delineation method used, as well as be compromised by the low PET image spatial resolution 
and associated partial volume effects (PVE) [18, 22], although this has never been thoroughly 
investigated. 
This study was therefore designed to assess the robustness of heterogeneity calculations based 
on TF analysis in terms of (i). absolute quantitative values and (ii). associated predictive value 
for therapy response assessment following concomitant radiochemotherapy in locally 
advanced oesophageal cancer patients (LAEC). The influence of both the tumour delineation 
methodology and the PVE was considered in this study, given their significant role in the 
process of determining heterogeneity indices.  
 
MATERIALS AND METHODS 
Patients 
Fifty consecutive patients (table 1) with confirmed LAEC treated with exclusive concomitant 
radiochemotherapy between 2004 and 2008 were retrospectively included. All patients 
underwent an 18F-FDG PET scan before initiating treatment as part of the staging procedure, 
and were subsequently treated with three courses of 5-fluorouracil/cisplatin and a median 
radiation dose of 60Gy given in 180cGy daily fractions delivered once daily, 5 days a week 
for 6–7 weeks. The analysis was carried out after an approval by the Institutional Ethics 
Review Board. 
 
18FDG-PET/CT Imaging 
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Patients fasted for at least 6 hours before injection of 5MBq/kg of 18FDG, administered 60 
minutes before data acquisition on a Philips GEMINI PET/CT scanner (Philips Medical 
Systems, Cleveland, OH, USA). CT data were acquired first (120kV and 100mAs, no 
contrast-enhancement). 3D PET data were acquired with 2min per bed position, and images 
were reconstructed using CT based attenuation correction (CT images were checked for 
artifacts that may lead to errors in quantification) and a 3D row-action maximum likelihood 
algorithm (RAMLA) using previously optimized protocol (2 iterations, relaxation parameter 
of 0.05, 5 mm 3-D Gaussian post-filtering, 4×4×4 mm3 voxels grid sampling) [25]. 
 
Response evaluation 
Response to therapy was evaluated one month after completion of treatment using CT and 
endoscopy based on Response Evaluation Criteria in Solid Tumours (RECIST) [26] with 
patients classified as non-responders including stable and progressive disease, or responders, 
including partial responders (PR) and complete responders (CR). In cases of PR or CR, 
patients also underwent fibroscopy. CR was confirmed by the absence of visible disease in the 
endoscopy and no viable tumour on biopsy. PR was confirmed by macroscopic residual 
(>10% viable) on biopsy. No discordance was observed between pathological, whenever 
available, and CT evaluation.  
 
18FDG-PET image analysis 
Intra-tumour heterogeneity parameters 
On the one hand, intra-tumour uptake heterogeneity was quantified considering only those 
indices that have been previously shown as robust considering image reconstruction and 
acquisition variability [23], and physiological reproducibility based on double baseline PET 
acquisitions [24]. Figure 1 illustrates the two types of heterogeneity parameters under 
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consideration. First, local heterogeneity parameters quantifying intensity variations between 
each voxel and its immediate neighbors only, averaged over the entire volume: entropy, 
homogeneity, dissimilarity. Second, regional heterogeneity parameters calculated through 
analysis at the level of groups of voxels and areas of various sizes and intensities: intensity 
variability (IV), size-zone variability (SZV), zone percentage (ZP), high intensity emphasis 
(HIE) [24].  
On the other hand, these same parameters were also shown to provide significant predictive 
value in identifying non-responders to radiochemotherapy in LAEC [18]. The area under the 
curve of the cumulative SUV-volume histogram (CHAUC) was included as an alternative 
global heterogeneity measure not previously evaluated for reproducibility and robustness. 
CHAUC quantifies percentage of total tumour volume above percentage threshold of SUVmax, a 
higher AUC representing a more homogeneous uptake [22]. Other global parameters such as 
skewness, variance, kurtosis or SUVCOV were excluded considering their previously 
demonstrated poor physiological reproducibility [24]. Finally, other standard parameters not 
describing heterogeneity, such as SUVmean and MATV were also included in this study for 
comparison purposes. 
 
Delineation approaches and PVE correction 
The heterogeneity parameters are extracted from functional tumour volumes delineated on the 
PET images. In order to investigate the dependency of heterogeneity quantification on tumour 
delineation, each oesophageal lesion was delineated on the baseline PET images using three 
different methods: a fixed threshold at 42% of the SUVmax (FT42%) [27], an adaptive 
threshold (AT) taking into account the measured contrast between the tumour (determined 
through a fixed threshold at 70% of the SUVmax) and the background uptake (determined 
through a ROI in the mediastinum) [28], and the Fuzzy Locally Adaptive Bayesian (FLAB) 
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algorithm [29]. The FLAB approach allows automatic tumour delineation by computing a 
probability of belonging to a given “class” (e.g. tumour or background) for each voxel within 
a 3D ROI containing the tumour and its surrounding background. This probability is 
calculated by taking into account the voxel’s intensity with respect to the statistical 
distributions (characterized by their mean and variance) of the voxels in the various regions of 
the image, as well as its spatial correlation with neighboring voxels in 3D. This approach has 
been previously validated on simulated and clinical datasets showing high combined 
accuracy, robustness and reproducibility, for the delineation of both homogeneous and 
heterogeneous MATVs [30-32]. 
In order to investigate the dependency of heterogeneity quantification on PVE, all PET 
images were corrected for PVE using a voxel-based iterative deconvolution approach 
including wavelet-based denoising previously validated for PET imaging [33]. MATVs were 
subsequently delineated on the deconvolved PET images using FLAB and all image derived 
parameters considered were extracted (figure 2). 
 
Statistical Analysis 
Statistical analyses were performed using MedcalcTM (MedCalc Software, Belgium). 
Correlation between parameters under investigation was assessed using Pearson’s correlation 
coefficients applied to parameters derived from FLAB delineations on the non-PVE corrected 
PET images. Considering the parameters’ values obtained with the FLAB delineation on the 
original non-PVE corrected PET images as reference, the variability of each PET image 
derived parameter with respect to either those derived using the two alternative delineation 
techniques considered, or derived from the corresponding PVE corrected images, was 
assessed using Bland-Altman analysis. This analysis provided mean and standard deviation 
(SD) of differences relative to the mean of the two measurements, as well as the respective 
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95% confidence intervals. Associated upper and lower reproducibility limits (URL and LRL 
respectively) defining the range of changes were calculated as mean±1.96×SD. Sub-analysis 
according to histology (adenocarcinoma vs. squamous cell carcinoma) was also carried out 
but no statistically significant differences were found and results were not included to reduce 
manuscript length.  
For each of the image derived parameters considered, their predictive value with respect to 
identifying different categories of patient responders was assessed using receiver operating 
characteristics (ROC) analysis. The area under the curve (AUC) was considered as a figure of 
merit to quantify the predictive value of each PET image derived index. In order to assess 
whether or not this predictive value was dependent on the tumour delineation approach used 
or PVE, differences between AUCs were assessed using Delong et al methodology [34], 
assuming a statistically significant difference with p<0.05.  
 
RESULTS 
Correlation between parameters 
Parameters under investigation exhibited different levels of cross correlation (table 2). The 
highest correlations were observed between MATV and intensity variability (r=-0.97), MATV 
and entropy (r=0.82), as well as between HIE and CHAUC (r=-0.97), homogeneity and 
dissimilarity (r=-0.93), entropy and ZP (r=-0.90). Some other parameters were moderately 
correlated (r=0.5 and 0.8) whereas others were not at all correlated, for instance MATV and 
SZV, HIE or CHAUC (r=-0.16, -0.22 and 0.07 respectively). 
 
Impact of tumour delineation method 
Using FT42% and AT led to substantially different functional volumes than using FLAB, 
with ~7±50% and -18±49% differences respectively (table 3). The associated upper and lower 
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reproducibility limits were very high (~75-100%), highlighting the fact that different 
delineation techniques led for some patients to highly different functional volumes.  
Several heterogeneity parameters derived from these largely different volumes were relatively 
independent on these differences. Such parameters included CHAUC, entropy, homogeneity, 
ZP and HIE with mean differences around 2% to -5% associated with a SD of ±4% to ±25% 
and upper and lower reproducibility limits from [-7%, +9%] for CHAUC to [-39%, +48%] for 
homogeneity. By comparison, SUVmean was equally dependent on the tumour delineation 
approach, with mean differences of about -1% to 5% and associated SD of ±21%. On the 
contrary, heterogeneity parameters such as IV, dissimilarity and SZV were the most sensitive 
to the delineated functional volume, resulting in mean differences of between 18% and -16% 
associated with a SD of ±20% to ±50% and higher upper and lower limits of 50-100%.  
 
Impact of partial volume effects 
Considering the FLAB delineation on the original non-corrected PET images as reference, the 
functional volume delineations on the PVC images led to relatively smaller volumes (mean 
differences of -14%) (table 3). Extracted heterogeneity parameters were overall less 
dependent on PVE corrections than they were on tumour delineation, most of the parameters 
exhibiting mean differences <10±15%, with the exception of IV, SZV and HIE. Similarly, 
upper and lower reproducibility limits were smaller than the corresponding values associated 
with the use of different tumour delineation methods, with the exception of SZV. The 
observed hierarchy in terms of dependence on either tumour delineation or PVE was also 
almost similar; the least sensitive parameters being the global and local heterogeneity 
characterization indices (CHAUC, entropy, homogeneity, dissimilarity) and a single regional 
heterogeneity parameter (ZP). The remaining regional heterogeneity parameters (IV, HIE, and 
SZV) were the most sensitive (URL and LRL of ~±95%). The impact on standard parameters 
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such as MATV (upper and lower limits of about ±20-30%) was similar to that of some 
heterogeneity parameters (HIE and IV). 
 
Impact on predictive value of baseline PET images 
According to RECIST there were 14 non-responders and 36 responders (24 partial and 12 
complete responders). Only results regarding the identification of non-responders vs. 
complete and partial responders are presented for readability purposes (table 4), as similar 
results were observed for the identification of complete responders vs. partial and non-
responders.  
All parameters under investigation when derived from FLAB delineated tumour volumes on 
the original baseline PET images (the chosen reference in this study) demonstrated high 
predictive value with AUC from 0.80 to 0.90, except for SUVmean, SZV, HIE and CHAUC 
(AUC of 0.60-0.72). This predictive value was mostly independent of the delineation method, 
although in absolute terms it was systematically higher when parameters were derived using 
FLAB delineated tumour volumes compared to the use of threshold-based ones (except for 
SUVmean), or the use of PVE corrected images. The only statistically significant differences 
regarding the delineation method were found for homogeneity and dissimilarity indices. More 
specifically, FLAB MATV derived homogeneity and dissimilarity measures resulted in AUCs 
of 0.86 and 0.85 respectively, whereas FT42% MATV derived homogeneity and dissimilarity 
measures resulted in statistically significantly lower AUC of 0.74 (p<0.05). In the case of 
PVE correction, only two heterogeneity parameters were significantly affected, with 
statistically significant improvements of the AUCs for CHAUC and HIE from 0.60 and 0.65 to 
0.77 and 0.83 respectively (p<0.04). 
 
DISCUSSION 
 12 
There is currently increasing interest in the use of new image derived indices and more 
particularly in those parameters which allow quantification of intra-tumour activity 
distribution heterogeneity. Our work brings new results concerning the robustness of such 
PET image derived indices with respect to the inherent low PET image resolution and the 
determination of functional tumour volumes within which the heterogeneity analysis is 
performed. The results are complementary to the previously established robustness 
evaluations with respect to reconstruction parameters [23], and physiological reproducibility 
on double baseline scans [24]. Such characterization in terms of robustness and 
reproducibility for these new indices to all these factors is a requirement in order to reliably 
propose their use and assess their potential impact in clinical research trials. The current study 
is the first to our knowledge, to investigate the dependence of several intra-tumour uptake 
heterogeneity quantification parameters on functional tumour volume delineation techniques 
and PVE correction. Within this context, we assessed the potential impact of such factors on 
the predictive value of these PET image derived parameters in terms of response classification 
for oesophageal carcinoma patients undergoing concomitant chemoradiotherapy.  
Among all considered tumour volume derived parameters, MATV was found to be the most 
sensitive parameter to the tumour delineation method used (about ±75-115% reproducibility 
limits). As already demonstrated in previous studies [5, 32], AT and FT42% led to smaller 
volumes than FLAB for larger, more heterogeneous uptakes (see figure 2 for an example), 
whereas much larger volumes were obtained for small, low uptake contrast lesions. As a 
consequence, FLAB delineations of large and heterogeneous tumours included more 
variability in voxel intensities than threshold-based methods which incorporated only high 
intensity areas. On the contrary for small, low uptake contrast tumours, threshold-based 
methods overestimated functional volumes by incorporating background voxels, leading to 
additional voxel intensity variability. 
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The respective robustness of the intra-tumour PET uptake heterogeneity parameters may be 
related to the type of heterogeneity information they quantify. For instance, entropy, 
homogeneity and dissimilarity are local heterogeneity parameters quantifying variations in the 
intensity between consecutive voxels that are then averaged over the entire volume. This 
should vary only slightly if one considers smaller or larger overall tumour volumes. These 
parameters were indeed among the least impacted by the delineation method (upper and lower 
reproducibility limits between <±10% to ±50%). On the other hand, regional heterogeneity 
parameters (ZP, HIE, IV, and SZV) quantify relationships between areas (groups of voxels) 
with different size and intensity. Among these, IV and SZV were found to be very sensitive to 
delineation (upper and lower limits between ±75% to ±110%), whereas ZP and HIE were 
more robust (upper and lower limits between ±20% to ±50%). There are different reasons that 
can account for the improved robustness of ZP and HIE over IV and SZV. In the case of ZP, 
the size of the characterized MATV is included in its calculation, normalizing over the 
differences of tumour volumes associated with different delineation approaches. Since the 
HIE measurement focuses on high intensity uptake regions, differences between the various 
MATV delineations is attenuated since all of them include at least the most active parts of the 
functional tumour volume. On the contrary, the least robust indices such as IV and SZV 
involve measurements which are neither focusing on high intensity regions nor normalized 
with respect to the size of the MATV volumes to characterize. Depending on the delineation 
result, the respective sizes and average intensity of each sub-region might be totally different 
on underestimated or over-estimated tumour volumes, leading to the low robustness of these 
two parameters. Finally, the only ‘global’ heterogeneity parameter included in this study 
(CHAUC) was the least sensitive to MATV delineation, explained by the fact that smaller or 
larger volume delineations would only lead to changes in the extremity of the cumulative 
histogram, subsequently not significantly altering the overall area under the histogram used in 
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the determination of the CHAUC, which may also be related to the limited ability of CHAUC to 
quantify actual uptake heterogeneity. 
Overall, heterogeneity characterization parameters that were the least dependent on the 
tumour delineation were CHAUC, a global estimation of intra-tumour heterogeneity, and 
entropy, characterizing local changes in consecutive voxels. Although slightly more 
dependent on the two factors considered, other robust heterogeneity parameters for local and 
regional intra-tumour heterogeneity characterization include homogeneity as well as ZP and 
HIE respectively. Consequently these indices could be used to quantify heterogeneity of 
MATVs delineated using less reliable methods with a small impact on both their absolute and 
predictive value within the context of classifying patient response to therapy. Given the 
current lack of consensus regarding the method of choice for PET image based MATV 
determination these parameters should be privileged since they are robust with respect to the 
delineation method employed. On the contrary, the use of the less robust heterogeneity 
parameters (dissimilarity for local characterization, SZV and IV for regional characterization) 
should be carefully considered particularly within the context of the MATV delineation 
method employed. 
On the other hand, it is worth noting that despite some high absolute differences between 
heterogeneity parameters derived from largely different MATVs due to different delineation 
approaches, only non-statistically significant differences were obtained concerning the 
associated predictive value of these parameters in terms of response to therapy prediction. 
This might be explained by the initial large differentiation between patient groups of response 
for most of the heterogeneity parameters considered in the current oesophageal cancer cohort.  
Clearly, this may not be the case in other cancer models and associated therapy regimes where 
a more significant impact on the response predictive value of the PET intra-tumour 
heterogeneity parameters might be observed. Another explanation would be that almost all 
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observed differences occurred in the same direction for most of the patients, leading to the 
same discrimination between distributions of response.  
Regarding the impact of PVE correction, the results were somehow different. Firstly, in 
absolute terms the impact of the PVE correction on the intra-tumour heterogeneity parameters 
was smaller compared that of the tumour delineation, with most of the parameters exhibiting 
lower and upper reproducibility limits of <±30%. Overall, parameters characterizing local 
heterogeneity at the scale of few voxels (entropy, homogeneity, dissimilarity) within the 
entire tumour were less sensitive than regional heterogeneity parameters (IV, ZP, SZV and 
HIE) that exhibited larger differences on the corrected images. This suggests that regional 
intra-tumour heterogeneity measurements are more sensitive to PVC related intensity changes 
within the corrected images. Amongst the regional parameters, ZP exhibited the lowest 
sensitivity to PVC, mainly because this measurement is mostly related to the size of the sub-
regions and not their intensity, which is the main aspect modified by PVC. Similarly with the 
robustness to the tumour delineation approach, the parameters that were least affected by the 
PVC were the CHAUC and entropy. 
Similarly to the delineation approach impact on response to therapy classification, no 
significant differences were found between the AUC based on the intra-tumour heterogeneity 
parameters derived from PVE corrected and those from the original images. The only 
exceptions were CHAUC and HIE for which their original limited predictive value (AUC of 
0.60 and 0.65) significantly improved after PVC (AUC of 0.77 and 0.83 respectively) 
(p<0.04). These results confirm the findings of the study that firstly introduced CH analysis 
for heterogeneity characterization suggesting that PVC improves the CHAUC curves [22]. On 
the other hand, the difference observed for the HIE parameter can be explained by the focus 
of this measurement on the high intensity tumour uptake areas that are the most altered by the 
PVE correction. Finally, this result could be also partly explained by the fact that these two 
 16 
parameters derived from the original baseline PET images (AUC below 0.7) were amongst 
the least predictive leaving more potential for improvement, in contrast  to the other 
parameters that were already characterized by AUC values superior to 0.80. 
Overall, despite large differences observed on the absolute values of derived heterogeneity 
parameters depending on the delineation method used and PVE correction, the resulting 
predictive values in identifying non responders were mostly unchanged, certainly because the 
different groups of response were characterized by largely different distributions. However, 
one issue that can be raised from the large observed variability on the absolute values of PET 
image derived heterogeneity parameters is the need for a rigorous standardization of image 
pre-processing techniques and associated analysis to allow reliable cut-off values in multi-
center studies using these indices. The physiological reproducibility of parameters such as 
entropy, homogeneity, dissimilarity or zone percentage providing quantification of local and 
regional intra-tumour uptake heterogeneity has been previously demonstrated. The present 
study has further highlighted the robustness of these parameters within the context of response 
to therapy studies, especially those involving multi-center analysis, showing that their 
predictive value is on the one hand not affected by PVE while on the other is relatively 
independent on the method used to delineate the tumour volumes to be analysed. 
We did not investigate the robustness of heterogeneity indices with respect to various 
reconstruction algorithms, which would complement the study of Galavis et al [23] and will 
require a full separate analysis of tumours list mode data reconstructed with different 
algorithms. This may be carried out in a future work. 
 
 
CONCLUSIONS 
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In this study, the robustness of PET image derived intra-tumour heterogeneity parameters 
with respect to the tumour volume where the analysis is performed and the PVE was 
investigated. Although differences in the absolute values of these parameters were obtained 
using different tumour delineation methods or after PVE correction, these differences did not 
always translate into a significant impact on their predictive value of response in an 
oesophageal cancer patient population undergoing concomitant chemoradiotherapy. Some 
parameters demonstrated superior robustness, although for some of them, such as for instance 
the global heterogeneity parameter CHAUC, these small differences did result in significant 
changes in the associated predictive value. In conclusion, parameters such as entropy and 
homogeneity or zone percentage for local or regional heterogeneity characterization 
respectively should be preferred, as they provide both a high differentiation power in terms of 
patient response prediction, and are robust with respect to the delineation method and PVE. 
 
Disclosure of Conflicts of Interest: No potential conflicts of interest were disclosed. 
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Parameter Number of patients (%) 
Gender  
  Male 45(90) 
  Female  5(10) 
 
Age  
  Range 45-84 
  Median 69 
 
Site  
  Upper esophagus 13(26) 
  Middle esophagus 20(40) 
  Lower esophagus 17(34) 
 
Histology type  
  Adenocarcinoma 14(28) 
  Squamous cell carcinoma   36(72) 
  
  
Histology differentiation  
  Well differentiated 14(28) 
  Moderately differentiated 12(24) 
  Poorly differentiated 5(10) 
  Unknown 19(38) 
 
TNM Stage  
           T1 7(14) 
           T2 8(16) 
           T3 24(48) 
           T4 11(22) 
           N0 20(40) 
           N1 30(60) 
           M0 34(68) 
           M1 16(32) 
 
AJCC Stage  
  I  4(8) 
  IIA  8(16) 
 IIB  6(12) 
 III 16(32) 
  IVA 16(32) 
 
Table 1. Patients characteristics 
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SUVmean 1.00 0.20 0.30 -0.10 -0.02 0.08 0.09 -0.40 0.40 -0.50 
MATV  1.00 0.82 0.69 -0.77 0.97 -0.16 -0.70 -0.22 0.07 
Entropy   1.00 0.60 -0.80 0.77 -0.25 -0.90 -0.08 -0.07 
Homogeneity    1.00 -0.93 0.80 -0.36 -0.42 -0.67 0.59 
Dissimilarity     1.00 -0.83 0.41 0.60 0.58 -0.45 
Intensity variability 
(IV) 
     1.00 -0.25 -0.62 -0.41 0.28 
Size-zone variability 
(SZV) 
      1.00 0.24 0.43 -0.32 
Zone percentage (ZP)        1.00 -0.18 0.32 
High intensity 
emphasis (HIE) 
        1.00 -0.97 
Area under the curve of 
the cumulative 
histogram (CHAUC) 
         1.00 
 
Table 2. Correlations (Pearson coefficients) between parameters derived from FLAB 
delineations on non-corrected PET images. Bold text denotes significant correlations. 
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Parameter Difference with respect to FLAB delineation on non-PVE corrected image 
FT42%  AT PVC 
mean±SD 
(%) 
LRL 
(%) 
URL 
(%) 
mean±SD 
(%) 
LRL 
(%) 
URL 
(%) 
mean±SD 
(%) 
LRL 
(%) 
URL 
(%) 
S
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d
 SUVmean -1±20.7 -41.5 39.6 5.2±21.1 -36.2 46.7 16.9±8.7 -0.2 34 
MATV 7.1±52 -94.9 109.1 -18.4±49.4 -115.1 78.3 -14.4±19.2 -32.0 23.2 
H
et
er
o
g
en
ei
ty
 
q
u
an
ti
fi
ca
ti
o
n
 
L
o
ca
l Entropy 1.5±9.4 -16.9 19.9 -4.3±12.6 -28.9 20.3 -4.6±5.3 -15.0 5.7 
Homogeneity 4.7±22.1 -38.7 48 -3.7±19.9 -42.8 35.4 4.2±10.9 -17.1 25.5 
Dissimilarity -5.3±28 -60.1 49.5 4.9±22.6 -39.3 49.1 -3.2±11.4 -25.5 19.1 
R
eg
io
n
al
 Intensity variability (IV) 7±50.1 -91.1 105.1 -16.2±47 -108.4 76 0.2±19.9 -38.8 39.2 
Size-zone variability (SZV) -6.5±48.9 -102.3 89.4 17.8±46.9 -74.2 109.8 3.3±47.9 -90.7 97.3 
Zone percentage (ZP) -2.4±20.4 -42.3 37.5 5.3±14.1 -22.4 32.9 10.3±11.6 -12.5 33 
High intensity emphasis (HIE) -4.6±19.8 -43.5 34.3 3.7±24.7 -44.6 52.1 -20.6±18.8 -57.5 16.3 
G
lo
b
al
 
Area under the curve of the 
cumulative histogram (CHAUC) 
1.2±4.1 -6.8 9.2 -1.1±6 -12.8 10.6 5±5.6 -5.9 15.9 
 
Table 3. Bland-Altman analysis (mean and standard deviation (SD), lower (LRL) and upper (URL) reproducibility limits, calculated as 
mean±1.96×SD) for differences between parameters derived from volumes delineated with fixed (FT42%) or adaptive (AT) thresholding, or on 
PVE corrected images, with respect to those derived from volumes delineated with FLAB. 
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Parameter AUC of ROC curves (NR vs. PR+CR) 
FT42% AT FLAB FLAB PVC 
SUVmean 0.66 0.65 0.64 0.60 
MATV 0.84 0.87 0.89 0.87 
Entropy 0.84 0.86 0.88 0.85 
Homogeneity 0.74* 0.82 0.86* 0.87 
Dissimilarity 0.74* 0.81 0.85* 0.88 
Intensity variability 
(IV) 
0.85 0.87 0.90 0.88 
Size-zone variability 
(SZV) 
0.66 0.70 0.72 0.86 
Zone percentage 
(ZP) 
0.74 0.78 0.81 0.82 
High intensity 
emphasis (HIE) 
0.59 0.65 0.65* 0.83* 
Area under the curve 
of the cumulative 
histogram (CHAUC) 
0.56 0.60 0.60* 0.77* 
* denotes statistically significant difference between the two AUCs. 
Table 4. Area under the ROC curve (AUC), regarding the identification of non-responders for 
each parameter depending on the delineation method and PVC. 
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Figure captions 
 
Figure 1. After delineation, MATV was resampled and extraction of local (a) and regional (b) 
heterogeneity parameters was performed. Local parameters were obtained by analysis of 
voxels along a direction (a) and areas of voxels sharing similar intensity (b). CHAUC was also 
computed. 
 
Figure 2. Workflow for the comparison of measurements depending on delineation method 
and PVC.  
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(A) (B) (C) 
 
Figure 3. Examples of ROC curves for the identification of non-responders obtained using 
the three delineations and the PVC image, for (A) homogeneity, (B) SZV and (C) CHAUC.
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